Arthur Malkani, MD
Orthopaedic Surgery · Louisville, KYNPI 1063444107
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $9,166,791 of the $9,617,365 with a category attached, or 95.3%. Stryker accounts for 99.9% of it on its own, with 34 other manufacturers making up the rest. Among orthopaedic surgery clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,220 payments — averaging $7883.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$9.6M
- Pacira Therapeutics, Inc.$2K
- Ferring Pharmaceuticals Inc.$1K
- Melinta Therapeutics, LLC$456
- Pacira Pharmaceuticals Incorporated$423
- Amgen$358
- plus $3K from 29 others
Across 55 payments — averaging $6005.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$330K
What the payments were for
- Royalty or licence$9,166,79195%
- Consulting fees$323,3753%
- Travel & lodging$97,6011%
- Food & beverage$29,5750%
- Education$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 880 | $9,610,141 |
| Pacira Therapeutics, Inc. | 93 | $1,747 |
| Ferring Pharmaceuticals Inc. | 61 | $1,233 |
| Melinta Therapeutics, LLC | 28 | $456 |
| Pacira Pharmaceuticals Incorporated | 19 | $423 |
| Amgen(2 entities) | 22 | $358 |
| Smith+Nephew | 8 | $312 |
| Johnson & Johnson(2 entities) | 12 | $255 |
| Dynasplint Systems Inc. | 6 | $232 |
| Sanofi-aventis U.S. LLC | 10 | $223 |
| Sanara Medtech Inc. | 4 | $200 |
| AbbVie(2 entities) | 10 | $181 |
| Vertex | 7 | $178 |
| Osteoremedies, LLC | 1 | $156 |
| Medacta USA, Inc. | 1 | $150 |
| Encore Medical, LP | 1 | $130 |
| Zyla Life Sciences, Inc. | 9 | $121 |
| Zimmer Biomet | 4 | $117 |
| Pfizer | 6 | $90 |
| Heron Therapeutics, Inc. | 4 | $90 |
| KCI USA, Inc. | 6 | $85 |
| Convatec Inc. | 4 | $82 |
| Solventum Corporation | 4 | $69 |
| Bioventus LLC | 3 | $64 |
| Davol Inc. | 2 | $50 |
| Avanos Medical | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 3 | $37 |
| Medtronic | 2 | $24 |
| Abbott | 1 | $24 |
| Orthofix Medical, Inc. | 2 | $24 |
| Linvatec Corporation | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Baudax Bio Inc. | 1 | $14 |
| Flowonix Medical Incorporated | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REUNION$9,192,724
- ACCOLADE$4,107,084
- TRIATHLON$3,818,328
- MAKO$683,712
- TRITANIUM$40,915
- RESTORATION$28,957
- TRIDENT$24,733
- MOBILE BEARING HIP SYSTEM$2,250
- PRIME SERIES$1,195
- INSIGNIA$953
- T2$897
- GAMMA$897
- ADAPT$897
- MAKOPLASTY$834
- NEW PRODUCT DEVELOPMENT$729
- GMRS$287
- Zilretta$222
- NONE$172
- GMK SPHERE$150
- JII Unicondylar Knee System$148
How this compares
$9,617,365 in reported general payments places this provider in the 95th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 39 | $2,106 |
| Amoxicillin | 126 | $319 |
| Clindamycin Hcl | 18 | $77 |
| Ondansetron Hcl | 12 | $63 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $29 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Louisville
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.5M
- Akbar NawabLouisville$1M
- Joseph GreeneLouisville$581K
- George QuillLouisville$304K
- Rodolfo Zamora RendichLouisville$292K
- Richard SweetLouisville$238K
- Frank BonnarensLouisville$146K
- Ryan EadsLouisville$99K
- Kevin HarreldLouisville$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.